Free Submission Public Relations &
Deutsch English

EpiCast Report: Atopic Dermatitis - Epidemiology Forecast to 2022

Global atopic dermatitis market: China & India saw 60% of all global cases in 2012

Print article Print article
2014-02-12 19:15:03 - EpiCast Report: Atopic Dermatitis - Epidemiology Forecast to 2022 - a new market research report on

Atopic dermatitis or atopic eczema is a chronic inflammatory skin disease characterized by itchy skin lesions and rashes. Though the condition affects people of all ages, it is primarily common among infants and children (Bowcock and Cookson, 2004). Due to its chronic and relapsing nature, atopic dermatitis presents a global public health concern, with reported lifetime prevalence ranging between 10%–20% in children and 1%–3% in adults (Larsen and Hanifin, 2002).

In general, the prevalence of atopic dermatitis is increasing worldwide, with high prevalence in western and developed nations compared with other parts of the world. However, recent trends demonstrate a gradual rise in prevalence in developing countries and plateauing prevalence in developed countries (Asher et al., 2006). Although atopic dermatitis is



not life-threatening, it has a huge impact on economic burden and quality of life of individuals (Carroll et al., 2005).

Our epidemiologists projected the prevalence of atopic dermatitis in the 9MM from 2012–2022 using country-specific studies and peer-reviewed journals that provided age- and sex-specific prevalence of atopic dermatitis in the respective markets. Atopic dermatitis prevalent cases are further segmented by severity. The forecast methodology was consistent across all the 9MM to allow for a meaningful comparison among them.

It is forecast that prevalent cases of atopic dermatitis in the 9MM will increase from 132.28 million in 2012 to 132.71 million cases in 2022 at an annual growth rate (AGR) of 0.10%. In 2012, China and India combined contributed 83.04 million cases, comprising more than 60% of the total prevalent cases in the 9MM.

Our epidemiological forecast projects a substantial increase in the lifetime prevalent cases of atopic dermatitis in the 9MM over the forecast period (2012–2022). As our epidemiologists used steady prevalence proportions of atopic dermatitis over the forecast period, the growth in prevalent cases in each market can be attributed to the change in population demographics in the respective markets, especially in the younger age groups as they comprise the highest proportion of the prevalent cases.

The forecast underscores the considerable psychosocial and economic burden inflicted by atopic dermatitis particularly among children. Governments in the respective markets should develop strategies to tackle the growing problem and direct appropriate interventions towards reducing various triggers inducing atopic dermatitis especially among young children (Williams et al., 2012).

Click for report details: ..

Browse all Healthcare and Medical Market Research Reports ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Latest Market Research Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Mike King
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact